Alzheimer's & Dementia

Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease

By Emily C. Collins, Ming Lu, Rose C Beck, Oskar Hansson

Trial in peopleBiomarkers

The paper

Emily C. Collins, Ming Lu, Rose C Beck, Oskar Hansson

Eli Lilly (United States)

Alzheimer's & Dementia, 1 Aug 2026

doi.org/10.1002/alz.71740 PubMed 42565262

medRxiv4 Oct 2026
Tool converts plasma pTau217 values across testing platforms
medRxiv5 Oct 2026
Blood eMTBR-tau linked to Alzheimer’s tangles at autopsy
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
Research Square4 Oct 2026
Brain diffusivity modifies plasma pTau217 links to pathology